Strategic Groupings Of US Biotechnology Initial Public Offerings And A Measure Of Their Market Influence

ASU Author/Contributor (non-ASU co-authors, if there are any, appear on document)
David Williams, Professor of Healthcare Management (Creator)
Appalachian State University (ASU )
Web Site:

Abstract: This study verifies the existence of strategic groups among biotechnology firms that have filed for an initial public offering (IPO). We found three distinct groupings based on the dimensions of competitive scope and growth. Differences also exist between these groupings and an aspect of market influence – the ability to attract strategic partners. We found that biotechnology IPOs that seek greater breadth in competitive scope and growths also have more alliance partners. This paper adds to our knowledge of the bio-pharmaceutical market-sector and the strategic intentions of firms in an emerging, disruptive industry and their ability to attract strategic coalition partners.

Additional Information

David Williams, Carlton Young, Richard Shewchuk & Haiyan Qu (2010). Strategic groupings of US biotechnology initial public offerings and a measure of their market influence, Technology Analysis & Strategic Management, 22:4, 399-415, DOI: 10.1080/09537321003714261. Publisher version of record available at:
Language: English
Date: 2010
Biotechnology, Strategic Groups, Initial Public Offering, Strategic Alliances

Email this document to